GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 745 filers reported holding GLAXOSMITHKLINE PLC in Q3 2016. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,068,000 | -70.4% | 24,764 | -70.2% | 2.44% | -12.0% |
| Q2 2016 | $3,606,000 | -7.7% | 83,213 | -13.6% | 2.77% | +9.6% |
| Q1 2016 | $3,906,000 | -3.0% | 96,328 | -3.5% | 2.52% | +5.3% |
| Q4 2015 | $4,026,000 | -2.9% | 99,778 | -7.5% | 2.40% | -1.9% |
| Q3 2015 | $4,147,000 | -11.9% | 107,863 | -4.6% | 2.44% | +1.0% |
| Q2 2015 | $4,709,000 | -7.9% | 113,071 | +2.1% | 2.42% | -11.5% |
| Q1 2015 | $5,111,000 | -12.5% | 110,742 | -19.0% | 2.73% | +3.6% |
| Q4 2014 | $5,840,000 | -16.3% | 136,646 | -9.9% | 2.64% | -2.0% |
| Q3 2014 | $6,974,000 | -18.0% | 151,701 | -4.6% | 2.69% | -9.4% |
| Q2 2014 | $8,501,000 | +1.6% | 158,948 | +1.5% | 2.97% | -2.1% |
| Q1 2014 | $8,365,000 | -1.7% | 156,559 | -1.7% | 3.03% | -0.6% |
| Q4 2013 | $8,506,000 | +5.9% | 159,318 | -0.5% | 3.05% | -1.1% |
| Q3 2013 | $8,033,000 | -4.3% | 160,121 | -4.7% | 3.08% | -5.4% |
| Q2 2013 | $8,394,000 | – | 167,981 | – | 3.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |